Proteins and Peptides
26 October 2016
EVARREST® Fibrin Sealant Patch Gains FDA Approval on Expanded Indication for General Hemostasis26 October 2016
ProMetic’s plasminogen meets primary and secondary end points in pivotal Phase 2/3 trial26 October 2016
Apitope Announces Enrolment of First Patient in Phase I Trial of ATX-GD-59 for the Treatment of Graves’ Disease25 October 2016
Protalix BioTherapeutics Doses First Patient in Global Phase III Clinical Trial of PRX-102 for the Treatment of Fabry Disease25 October 2016
Stealth BioTherapeutics Initiates Phase 2 Study of Elamipretide in Patients Hospitalized With Congestive Heart Failure24 October 2016
Alphamab Starts Clinical Trial on Its First Novel Biologics KN015, a Long-acting FSH, for In Vitro Fertilization (IVF)20 October 2016
Eiger Announces First Patient Dosed in Phase 2 Study of Pegylated Interferon Lambda in Hepatitis D Virus (HDV) Infection16 October 2016
Abicipar Pegol PALM Study Phase 2 Data in Diabetic Macular Edema (DME) Presented at 2016 AAO Annual Meeting11 October 2016
Hansa Medical: First patient treated with IdeS in Phase II study in acquired Thrombotic Thrombocytopenic Purpura (TTP)9 October 2016
Novo Nordisk receives Complete Response Letter in the US for faster-acting insulin aspart7 October 2016
BARDA Awards $37.6 million Contract to Sanofi to Supply Leukine® (sargramostim) for Potential Public Health Emergency30 September 2016
CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities30 September 2016
Aurinia Announces That Voclosporin Achieves Primary and All Pre-Specified Secondary Endpoints in Its Phase IIb AURA-LV Study for Lupus Nephritis (LN)27 September 2016
Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients26 September 2016
First Patient Dosed in CANbridge’s CAN-008 Phase I/II Trial in Newly-Diagnosed Glioblastoma Multiforme in Taiwan26 September 2016
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA) for Pancreatic Cancer26 September 2016
Cinfa Biotech starts second clinical study of pegfilgrastim biosimilar candidate B12019News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports